Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Other Non-Current Liabilities (2016 - 2023)

Alaunos Therapeutics (TCRT) has disclosed Other Non-Current Liabilities for 10 consecutive years, with $28000.0 as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Other Non-Current Liabilities changed N/A year-over-year to $28000.0, compared with a TTM value of $28000.0 through Mar 2023, changed N/A, and an annual FY2022 reading of $28000.0, changed N/A over the prior year.
  • Other Non-Current Liabilities was $28000.0 for Q1 2023 at Alaunos Therapeutics, roughly flat from $28000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $28000.0 in Q2 2022 and bottomed at $28000.0 in Q2 2022.